• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病早期非运动特征及危险因素的荟萃分析。

Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

机构信息

Institute of Neurology, University College London, London, United Kingdom.

出版信息

Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15.

DOI:10.1002/ana.23687
PMID:23071076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3556649/
Abstract

OBJECTIVE

To evaluate the association between diagnosis of Parkinson disease (PD) and risk factors or early symptoms amenable to population-based screening.

METHODS

A systematic review and meta-analysis of risk factors for PD.

RESULTS

The strongest associations with later diagnosis of PD were found for having a first-degree or any relative with PD (odds ratio [OR], 3.23; 95% confidence interval [CI], 2.65-3.93 and OR, 4.45; 95% CI, 3.39-5.83) or any relative with tremor (OR, 2.74; 95% CI, 2.10-3.57), constipation (relative risk [RR], 2.34; 95% CI, 1.55-3.53), or lack of smoking history (current vs never: RR, 0.44; 95% CI, 0.39-0.50), each at least doubling the risk of PD. Further positive significant associations were found for history of anxiety or depression, pesticide exposure, head injury, rural living, beta-blockers, farming occupation, and well-water drinking, and negative significant associations were found for coffee drinking, hypertension, nonsteroidal anti-inflammatory drugs, calcium channel blockers, and alcohol, but not for diabetes mellitus, cancer, oral contraceptive pill use, surgical menopause, hormone replacement therapy, statins, acetaminophen/paracetamol, aspirin, tea drinking, history of general anesthesia, or gastric ulcers. In the systematic review, additional associations included negative associations with raised serum urate, and single studies or studies with conflicting results.

INTERPRETATION

The strongest risk factors associated with later PD diagnosis are having a family history of PD or tremor, a history of constipation, and lack of smoking history. Further factors also but less strongly contribute to risk of PD diagnosis or, as some premotor symptoms, require further standardized studies to demonstrate the magnitude of risk associated with them.

摘要

目的

评估帕金森病(PD)诊断与可进行人群筛查的风险因素或早期症状之间的关联。

方法

对 PD 的风险因素进行系统回顾和荟萃分析。

结果

与 PD 后期诊断相关性最强的因素是一级亲属或任何亲属患有 PD(比值比 [OR],3.23;95%置信区间 [CI],2.65-3.93 和 OR,4.45;95% CI,3.39-5.83)或任何亲属患有震颤(OR,2.74;95% CI,2.10-3.57)、便秘(相对风险 [RR],2.34;95% CI,1.55-3.53)或无吸烟史(当前与从不:RR,0.44;95% CI,0.39-0.50),每种情况都使 PD 的风险增加一倍以上。还发现了与焦虑或抑郁史、农药暴露、头部外伤、农村生活、β受体阻滞剂、农业职业和饮用井水、咖啡饮用、高血压、非甾体抗炎药、钙通道阻滞剂和酒精呈负显著关联,但与糖尿病、癌症、口服避孕药使用、手术绝经、激素替代疗法、他汀类药物、对乙酰氨基酚/扑热息痛、阿司匹林、饮茶、全身麻醉史或胃溃疡无关。在系统综述中,还发现了与血清尿酸升高呈负相关的其他关联,以及一些单项研究或存在矛盾结果的研究。

解释

与 PD 后期诊断相关的最强风险因素是有 PD 或震颤家族史、有便秘史和无吸烟史。进一步的因素也会增加 PD 诊断的风险,但程度较弱,或者作为一些前驱症状,需要进一步进行标准化研究以证明与它们相关的风险程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/343033496459/ana0072-0893-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/0df68f7b14d3/ana0072-0893-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/f754e8cbd135/ana0072-0893-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/51030e360edc/ana0072-0893-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/343033496459/ana0072-0893-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/0df68f7b14d3/ana0072-0893-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/f754e8cbd135/ana0072-0893-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/51030e360edc/ana0072-0893-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed36/3556649/343033496459/ana0072-0893-f4.jpg

相似文献

1
Meta-analysis of early nonmotor features and risk factors for Parkinson disease.帕金森病早期非运动特征及危险因素的荟萃分析。
Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15.
2
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
3
Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period.口服非甾体抗炎药(单剂量)用于产后早期会阴部疼痛
Cochrane Database Syst Rev. 2016 Jul 14;7(7):CD011352. doi: 10.1002/14651858.CD011352.pub2.
4
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis.帕金森病与吸烟、农村生活、饮用井水、务农及农药使用之间的关联:系统评价与荟萃分析
PLoS One. 2016 Apr 7;11(4):e0151841. doi: 10.1371/journal.pone.0151841. eCollection 2016.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.戒烟药物和电子烟:系统评价、网络荟萃分析和成本效益分析。
Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590.

引用本文的文献

1
Multi-omics signature of healthy versus unhealthy lifestyles reveals associations with diseases.健康与不健康生活方式的多组学特征揭示了与疾病的关联。
Hum Genomics. 2025 Aug 30;19(1):101. doi: 10.1186/s40246-025-00817-7.
2
Acupuncture for Parkinson's Disease: A Narrative Review of Clinical Efficacy and Mechanistic Insights.针灸治疗帕金森病:临床疗效与作用机制的叙述性综述
Neuropsychiatr Dis Treat. 2025 Aug 22;21:1731-1750. doi: 10.2147/NDT.S532027. eCollection 2025.
3
Human Glucose Transporters in Health and Selected Neurodegenerative Diseases.

本文引用的文献

1
Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results.农药使用与帕金森病有关吗?研究结果异质性的一些线索。
Environ Health Perspect. 2012 Mar;120(3):340-7. doi: 10.1289/ehp.1103881.
2
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies.非甾体抗炎药作为帕金森病的病情改善药物:来自观察性研究的证据
Cochrane Database Syst Rev. 2011 Nov 9(11):CD008454. doi: 10.1002/14651858.CD008454.pub2.
3
Meta-analysis of the relationship between Parkinson disease and melanoma.
健康与特定神经退行性疾病中的人类葡萄糖转运蛋白
Int J Mol Sci. 2025 Jul 31;26(15):7392. doi: 10.3390/ijms26157392.
4
Patterns and predictors of orbitofrontal sulcogyral morphology in a nonclinical population.非临床人群眶额沟回形态的模式及预测因素
Imaging Neurosci (Camb). 2024 Dec 19;2. doi: 10.1162/imag_a_00389. eCollection 2024.
5
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
6
Parkinson's Disease Database in the Middle East, North Africa, and South Asia Countries.中东、北非和南亚国家的帕金森病数据库。
Int J Public Health. 2025 Jun 2;70:1608016. doi: 10.3389/ijph.2025.1608016. eCollection 2025.
7
Single-cell multiomics identifies both shared and unique features of immune dysfunction in Parkinson's disease and inflammatory bowel disease colon, plasma and stool.单细胞多组学揭示了帕金森病和炎症性肠病在结肠、血浆和粪便中免疫功能障碍的共同特征和独特特征。
bioRxiv. 2025 Jun 11:2025.04.29.651228. doi: 10.1101/2025.04.29.651228.
8
Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohort.β-肾上腺素能受体药物与帕金森病进展:大型汇总发病队列中的里程碑事件
NPJ Parkinsons Dis. 2025 Jul 3;11(1):198. doi: 10.1038/s41531-025-01014-y.
9
Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson's disease motor severity.农药暴露与生活方式与帕金森病运动严重程度之间关联的纵向评估。
NPJ Parkinsons Dis. 2025 Jun 12;11(1):164. doi: 10.1038/s41531-025-01010-2.
10
Predicting dementia in people with Parkinson's disease.预测帕金森病患者的痴呆症。
NPJ Parkinsons Dis. 2025 May 13;11(1):126. doi: 10.1038/s41531-025-00983-4.
帕金森病与黑色素瘤关系的荟萃分析。
Neurology. 2011 Jun 7;76(23):2002-9. doi: 10.1212/WNL.0b013e31821e554e.
4
Traumatic Encephalopathy (`Punch Drunk') of Professional Pugilists.职业拳击手的创伤性脑病(“拳击醉酒综合征”)
J Neurol Psychopathol. 1934 Jul;15(57):20-8. doi: 10.1136/jnnp.s1-15.57.20.
5
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.对序列变异进行推断以识别帕金森病的遗传风险:全基因组关联研究的荟萃分析。
Lancet. 2011 Feb 19;377(9766):641-9. doi: 10.1016/S0140-6736(10)62345-8. Epub 2011 Feb 1.
6
When does Parkinson disease start?帕金森病何时开始?
Arch Neurol. 2010 Jul;67(7):798-801. doi: 10.1001/archneurol.2010.135.
7
Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis.抗炎药物与帕金森病风险:一项荟萃分析。
Neurology. 2010 Mar 23;74(12):995-1002. doi: 10.1212/WNL.0b013e3181d5a4a3.
8
Parkinson's disease and cancer risk: a systematic review and meta-analysis.帕金森病与癌症风险:系统评价与荟萃分析。
Cancer Causes Control. 2010 May;21(5):697-707. doi: 10.1007/s10552-009-9497-6. Epub 2010 Jan 7.
9
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析的首选报告项目:PRISMA声明。
BMJ. 2009 Jul 21;339:b2535. doi: 10.1136/bmj.b2535.
10
Neuroinflammation in Parkinson's disease: a target for neuroprotection?帕金森病中的神经炎症:神经保护的一个靶点?
Lancet Neurol. 2009 Apr;8(4):382-97. doi: 10.1016/S1474-4422(09)70062-6.